CLEARSIDE BIOMEDICAL, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT November 23, 2015Investor Rights Agreement • January 8th, 2016 • Clearside Biomedical, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 8th, 2016 Company Industry JurisdictionThis Third Amended and Restated Investor Rights Agreement (this “Agreement”) is entered into as of the 23rd day of November, 2015, by and among Clearside Biomedical, Inc., a Delaware corporation (the “Company”), and the holders of shares of the Company’s Preferred Stock from time to time outstanding (the “Investor Stock”) listed on Exhibit A attached hereto (the “Investors”).
SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • September 9th, 2014 • Clearside Biomedical, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 9th, 2014 Company Industry JurisdictionThis Second Amended and Restated Investor Rights Agreement (this “Agreement”) is entered into as of the 29th day of August, 2014, by and among Clearside Biomedical, Inc., a Delaware corporation (the “Company”), and the holders of shares of the Company’s Preferred Stock from time to time outstanding (the “Investor Stock”) listed on Exhibit A attached hereto (the “Investors”).